Presymptomatic apolipoprotein e genotyping for Alzheimer's disease risk assessment and prevention

Alzheimer's and Dementia

Volumn 7, Issue 4, 2011, Pages

  Schipper, Hyman M ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Alzheimer disease; Apolipoprotein E; Ethics; Genetic testing; Mild cognitive impairment; Prevention; Risk factor

Indexed keywords

APOLIPOPROTEIN E;

ALZHEIMER DISEASE; ARTICLE; BEHAVIORAL SCIENCE; GENETIC ANALYSIS; GENOTYPE; HEALTH BEHAVIOR; HUMAN; MEDICAL ETHICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ALZHEIMER DISEASE; APOLIPOPROTEINS E; GENOTYPE; HUMANS; NEUROPSYCHOLOGICAL TESTS; RISK ASSESSMENT;

EID: 79960845369     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2010.06.003     Document Type: Article

References (43)

1. H.C. Hendrie Epidemiology of dementia and Alzheimer's disease Am J Geriatr Psychiatry 6 2 Suppl 1 1998 S3 18
2. L.E. Hebert, P.A. Scherr, J.L. Bienias, D.A. Bennett, and D.A. Evans Alzheimer disease in the US population: prevalence estimates using the 2000 census Arch Neurol 60 2003 1119 1122 (Pubitemid 36975801)
3. H. Chertkow, H. Bergman, H.M. Schipper, S. Gauthier, R. Bouchard, and S. Fontaine Assessment of suspected dementia Can J Neurol Sci 28 Suppl 1 2001 S28 S41
4. R.C. Petersen, G.E. Smith, S.C. Waring, R.J. Ivnik, E.G. Tangalos, and E. Kokmen Mild cognitive impairment: clinical characterization and outcome Arch Neurol 56 1999 303 308 (Pubitemid 29120227)
5. R.L. Ernst, and J.W. Hay The US economic and social costs of Alzheimer's disease revisited Am J Public Health 84 1994 1261 1264 (Pubitemid 24250694)
6. Z.S. Khachaturian A roadmap for the prevention of dementia II: Leon Thal Symposium 2008 Alzheimers Dement 5 2009 85 92
7. Z.S. Khachaturian, and A.S. Khachaturian Prevent Alzheimer's disease by 2020: a national strategic goal Alzheimers Dement 5 2009 81 84
8. Schipper HM. Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment. Neurobiol Aging (in press).
9. A. Cedazo-Minguez, R.F. Cowburn, and E. Apolipoprotein a major piece in the Alzheimer's disease puzzle J Cell Mol Med 5 2001 254 266
10. V.I. Zannis, D. Kardassis, and E.E. Zanni Genetic mutations affecting human lipoproteins, their receptors, and their enzymes Adv Hum Genet 21 1993 145 319
11. G.-Y.R. Hsiung, and A.D. Sadovnick Genetics and dementia: risk factors, diagnosis, and management Alzheimers Dement 3 2007 418 427 (Pubitemid 47535130)
12. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, and G.W. Small Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923 (Pubitemid 23275809)
13. S. Seshadri, D.A. Drachman, and C.F. Lippa Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know Arch Neurol 52 1995 1074 1079
14. N.T. Aggarwal, R.S. Wilson, T.L. Beck, J.L. Bienias, E. Berry-Kravis, and D.A. Bennett The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment Neurocase 11 2005 3 7 (Pubitemid 40372854)
15. D.P. Devanand, G.H. Pelton, D. Zamora, X. Liu, M.H. Tabert, and M. Goodkind Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment Arch Neurol 62 2005 975 980 (Pubitemid 40973460)
16. G.Y. Hsiung, A.D. Sadovnick, and H. Feldman Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging CMAJ 171 2004 863 867 (Pubitemid 39371553)
17. M.C. Tierney, J.P. Szalai, W.G. Snow, and R.H. Fisher The prediction of Alzheimer disease. The role of patient and informant perceptions of cognitive deficits Arch Neurol 53 1996 423 427 (Pubitemid 26143641)
18. Statement on use of apolipoprotein E testing for Alzheimer disease American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease JAMA 274 1995 1627 1629
19. H. Chertkow Introduction: the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia, 2006 Alzheimers Dement 3 2007 262 265 (Pubitemid 47610325)
20. R.C. Petersen, G.E. Smith, R.J. Ivnik, E.G. Tangalos, D.J. Schaid, and S.N. Thibodeau Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals JAMA 273 1995 1274 1278
21. A. Bizzarro, C. Marra, A. Acciarri, A. Valenza, F.D. Tiziano, and C. Brahe Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease Dement Geriatr Cogn Disord 20 2005 254 261 (Pubitemid 41291577)
22. J. Poirier, M.C. Delisle, R. Quirion, I. Aubert, M. Farlow, and D. Lahiri Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease Proc Natl Acad Sci U S A 92 1995 12260 12264 (Pubitemid 26014050)
23. J.E. Hixson, and D.T. Vernier Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI J Lipid Res 31 1990 545 548 (Pubitemid 20107994)
24. C. Patterson, J.W. Feightner, A. Garcia, and C. MacKnight General risk factors for dementia: a systematic evidence review Alzheimers Dement 3 2007 341 347 (Pubitemid 47535136)
25. R. Brookmeyer, S. Gray, and C. Kawas Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset Am J Public Health 88 1998 1337 1342 (Pubitemid 28402270)
26. C. Patterson, J.W. Feightner, A. Garcia, and C. MacKnight Primary prevention of dementia Alzheimers Dement 3 2007 348 354 (Pubitemid 47535133)
27. S.G. Post, P.J. Whitehouse, R.H. Binstock, T.D. Bird, S.K. Eckert, and L.A. Farrer The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective JAMA 277 1997 832 836 (Pubitemid 27111321)
28. E.W. Almqvist, M. Bloch, R. Brinkman, D. Craufurd, and M.R. Hayden A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease Am J Hum Genet 64 1999 1293 1304 (Pubitemid 30468747)
29. A.M. Codori, P.R. Slavney, A. Rosenblatt, and J. Brandt Prevalence of major depression one year after predictive testing for Huntington's disease Genet Test 8 2004 114 119 (Pubitemid 39096752)
30. T.B. Robins Wahlin To know or not to know: a review of behaviour and suicidal ideation in preclinical Huntington's disease Patient Educ Couns 65 2007 279 287
31. J.S. Roberts, L.A. Cupples, N.R. Relkin, P.J. Whitehouse, and R.C. Green Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study J Geriatr Psychiatry Neurol 18 2005 250 255 (Pubitemid 41736393)
32. R.C. Green, J.S. Roberts, L.A. Cupples, N.R. Relkin, P.J. Whitehouse, and T. Brown Disclosure of APOE genotype for risk of Alzheimer's disease N Engl J Med 361 2009 245 254
33. J.S. Roberts Anticipating response to predictive genetic testing for Alzheimer's disease: a survey of first-degree relatives Gerontologist 40 2000 43 52 (Pubitemid 30170189)
34. J.S. Roberts, S.A. LaRusse, H. Katzen, P.J. Whitehouse, M. Barber, and S.G. Post Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease Alzheimer Dis Assoc Disord 17 2003 86 93 (Pubitemid 36736842)
35. T.R. Fanshawe, A.T. Prevost, J.S. Roberts, R.C. Green, D. Armstrong, and T.M. Marteau Explaining behavior change after genetic testing: the problem of collinearity between test results and risk estimates Genet Test 12 2008 381 386
36. P.H. Robert, S. Schuck, B. Dubois, J.P. Olie, J.P. Lepine, and T. Gallarda Screening for Alzheimer's disease with the short cognitive evaluation battery Dement Geriatr Cogn Disord 15 2003 92 98 (Pubitemid 36098762)
37. C.D. Zick, C.J. Mathews, J.S. Roberts, R. Cook-Deegan, R.J. Pokorski, and R.C. Green Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior Health Aff (Millwood) 24 2005 483 490 (Pubitemid 40528968)
38. M.R. Cassidy, J.S. Roberts, T.D. Bird, E.J. Steinbart, L.A. Cupples, and C.A. Chen Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease Alzheimers Dement 4 2008 406 413
39. M. Lock, J. Freeman, G. Chilibeck, B. Beveridge, and M. Padolsky Susceptibility genes and the question of embodied identity Med Anthropol Q 21 2007 256 276
40. S.G. Post Future scenarios for the prevention and delay of Alzheimer disease onset in high-risk groups. An ethical perspective Am J Prev Med 16 1999 105 110 (Pubitemid 29100736)
41. C.M. Bojanowski, D. Shen, E.Y. Chew, B. Ning, K.G. Csaky, and W.R. Green An apolipoprotein E variant may protect against age-related macular degeneration through cytokine regulation Environ Mol Mutagen 47 2006 594 602 (Pubitemid 44701595)
42. Roses AD, Lutz MW, Amrine-Madsen H, Saunders AM, Crenshaw DG, Sundseth SS, et al. A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J (in press).
43. D. Harold, R. Abraham, P. Hollingworth, R. Sims, A. Gerrish, and M.L. Hamshere Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease Nat Genet 41 2009 1088 1093